IL6 and rheumatic disorder: Adiponectin the second adipokine most evaluated in rheumatic diseases possesses a complex role with some anti-inflammatory effects as well as inhibition of TNF-α and IL-6 production and the induction of IL-10 synthesis[34,37,38].